Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities (Q43926172)
scientific article published in April 2002
Language:
(P31) (Q13442814)
(P304) 241-248
(P407) (Q1860)
(P433) 1
(P478) 301
(P577) Monday, April 1, 2002
(P921) (Q128406)
(P1433) (Q1500272)
(P1476) "Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities" (language: en)
(P2093) Alexandre Trifilieff
Daniel Wyss
Christoph Walker
Lazzaro Mazzoni
Rene Hersperger
other details
description scientific article published in April 2002

External Links